Şunu aradınız:: antistofniveau (Danca - İngilizce)

antistofniveau >100 ie/l bør opretholdes.
antibody levels >100 iu/l should be maintained.

resultaterne indikerer et samlet fald i antistofniveau over tid.
the results indicate an overall decline in antibody levels over time.

det lave antistofniveau kan være medfødt eller have udviklet sig med alderen.
the low levels of antibodies may be inherited or may have developed as you have grown older.

prevenar 13 fremkaldte et forhøjet antistofniveau efter hver dosis prevenar 13.
prevenar 13 elicited increased antibody levels after each dose of prevenar 13.

immunisering fra afkom af vaccinerede fugle bør derfor udsættes indtil dette antistofniveau er faldet.
immunisation of progeny from vaccinated birds should therefore be delayed until such antibodies have declined.

immunisering af afkom af vaccinerede fugle bør derfor udsættes, indtil dette antistofniveau er faldet.
immunisation of progeny from vaccinated birds should therefore be delayed until such antibodies have declined.

for hpv- vacciner er der ikke blevet identificeret et minimalt antistofniveau, som er associeret med beskyttelse.
24 11 15

antistofniveau > 100 ie/l bør opretholdes hos hbsag- og hbv-dna-negative patienter.
antibody levels >100 iu/l should be maintained in hbsag and hbv-dna negative patients.

for parvovirus havde 73- 100 % af hundene beskyttende antistofniveau, og for parainfluenzavirus 73-97 %.
the percentage of dogs with protective levels of antibodies for parvovirus ranged from 73 to 100% and for parainfluenza virus 73 to 97%.

efter et 3-dosis-vaccinationsprogram havde mindst 95,7 % af spædbørnene udviklet serobeskyttende eller seropositivt antistofniveau mod alle vaccinens antigener.
after a 3-dose primary vaccination schedule, at least 95.7% of infants had developed seroprotective or seropositive antibody levels against each of the vaccine antigens.

efter en boostervaccination (efter 4. dosis) havde mindst 98,4 % af børnene udviklet serobeskyttende eller seropositivt antistofniveau mod alle vaccinens antigener.
after booster vaccination (post-dose 4), at least 98.4% of children had developed seroprotective or seropositive antibody levels against each of the vaccine antigens.

en måned efter den fjerde dosis opnåede 95. 8% af de vaccinerede beskyttende antistofniveauer.
one month after the fourth dose 95.8% of vaccinees achieved seroprotective levels of antibody.